Search Results

You are looking at 11 - 20 of 489 items for :

  • Refine by Access: All x
Clear All
Full access

Hans C. Lee, Victor Mulanovich, and Yago Nieto

brain MRI showed a 1.7 × 2.0-cm periventricular lesion in the left centrum semiovale involving the white matter with peripheral T2 enhancement ( Figure 1A ). Results of cerebrospinal fluid (CSF) cellular, biochemical, and routine microbiology studies

Full access

Karolina Kata, Juan C. Rodriguez-Quintero, Octavio D. Arevalo, Jackie J. Zhang, Meenakshi Bidwai Bhattacharjee, Cornelius Ware, Antonio Dono, Roy Riascos-Castaneda, Nitin Tandon, Angel Blanco, Yoshua Esquenazi, Leomar Y. Ballester, Mark Amsbaugh, Arthur L. Day, and Jay-Jiguang Zhu

, next-generation sequencing (NGS) results, and MRI features. We retrospectively analyzed AEs according to the CTCAE, version 5.0. Results Median age at diagnosis was 22 years (range, 14–66 years), 60% of the cohort was male, and 60% had grade III

Full access

Ghadeer Olleik, Wassim Kassouf, Armen Aprikian, Jason Hu, Marie Vanhuyse, Fabio Cury, Stuart Peacock, Elin Bonnevier, Ebba Palenius, and Alice Dragomir

Health, Inc.), MRI, and Prostarix (Metabolon, Inc.) could be used for screening. 17 – 23 Furthermore, once diagnosed with PCa, patients might benefit from a group of interventions developed to distinguish aggressive cancers (that require treatment) from

Full access

Silviya K. Meletath, Dean Pavlick, Tim Brennan, Roy Hamilton, Juliann Chmielecki, Julia A. Elvin, Norma Palma, Jeffrey S. Ross, Vincent A. Miller, Philip J. Stephens, George Snipes, Veena Rajaram, Siraj M. Ali, and Isaac Melguizo-Gavilanes

weeks 3 and brain MRIs were obtained every 8 weeks. Tumor response was determined using the Macdonald criteria. 4 A 25-year-old man presented to our clinic in February 2013, after being diagnosed with a residual/recurrent high-grade glioma thought to

Full access

Fengting Yan, Kristine J. Rinn, Jonathon A. Kullnat, Aimee Y. Wu, Maura D. Ennett, Elizabeth L. Scott, and Henry G. Kaplan

deruxtecan (T-DXd) in May 2020 due to systemic disease progression. After one dose of T-DXd, she developed subacute onset of dysarthria and gait instability. Brain MRI showed extensive abnormal enhancement within the cerebellar folia, with associated sulcal

Full access

Vishnu Sampathkumar,, Dinesh Kumar, Nisarga Prasad, Pardeep Kumar Singh, Jitender Saini, Nishanth Sadhashiv, Uday Krishna, and Chandana Nagaraj

Full access

Jonathan W. Riess, Seema Nagpal, Joel W. Neal, and Heather A. Wakelee

multiple lymph nodes. MRI of the brain was negative for intracranial disease. The patient was initially treated with carboplatin and pemetrexed for 6 cycles followed by continuation maintenance pemetrexed for 17 cycles, until systemic progression was

Full access

James S. Blachly, Gerard Lozanski, David M. Lucas, Michael R. Grever, Kari Kendra, and Leslie A. Andritsos

months. Unfortunately, after this treatment period, a new satellite nodule developed proximal to the site of the prior excision. Results of PET/CT and MRI scans showed another deeper lesion medially in the midportion of the right arm ( Figure 1 ). Notably

Full access

Lucas Vieira dos Santos, João Paulo Lima, Kathia Cristina Abdalla, Arinilda Campos Bragagnoli, Florinda Almeida Santos, Alexandre dos Anjos Jácome, and Fabiano Elias Porto

. The bone scan showed moderate uptake in the diaphyses of the left tibia and fibula, the distal right humerus, and the proximal radii and femurs bilaterally ( Figure 1 ). MRI performed during this round of imatinib showed ill-defined areas in bone

Full access

Amy Zhou, Manik Amin, Kathryn J. Fowler, Elizabeth M. Brunt, Jesse Keller, and Benjamin Tan

abdominal MRI ( Figure 2A ). Next-generation sequencing of her tumor from the initial biopsy demonstrated a single nucleotide variant in the EGFR gene locus R521K. This polymorphism is of unclear clinical significance in hepatobiliary tract malignancies